Estrella Immunopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESLA and other ETFs, options, and stocks.About ESLA
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
CEOCheng Liu
CEOCheng Liu
Employees—
Employees—
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2022
Founded2022
Employees—
Employees—
ESLA Key Statistics
Market cap75.53M
Market cap75.53M
Price-Earnings ratio-5.38
Price-Earnings ratio-5.38
Dividend yield—
Dividend yield—
Average volume155.39K
Average volume155.39K
High today$2.15
High today$2.15
Low today$1.84
Low today$1.84
Open price$1.94
Open price$1.94
Volume80.86K
Volume80.86K
52 Week high$3.15
52 Week high$3.15
52 Week low$0.7301
52 Week low$0.7301
Stock Snapshot
The current Estrella Immunopharma(ESLA) stock price is $1.98, with a market capitalization of 75.53M. The stock trades at a price-to-earnings (P/E) ratio of -5.38.
On 2025-12-07, Estrella Immunopharma(ESLA) stock traded between a low of $1.84 and a high of $2.15. Shares are currently priced at $1.98, which is +7.6% above the low and -8.1% below the high.
The Estrella Immunopharma(ESLA)'s current trading volume is 80.86K, compared to an average daily volume of 155.39K.
During the past year, Estrella Immunopharma(ESLA) stock moved between $0.73 at its lowest and $3.15 at its peak.
During the past year, Estrella Immunopharma(ESLA) stock moved between $0.73 at its lowest and $3.15 at its peak.
People also own
Based on the portfolios of people who own ESLA. This list is generated using Robinhood data, and it’s not a recommendation.